Patients Moving beyond intent: Building more diverse clinical trials Improving representation is not simply about increasing awareness or setting enrolment targets. It requires identifying and removing the barriers.
R&D Sponsored Webinar recap: The future of cell and gene therapy in rare d... For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them
Digital Initial leap of faith inspires today’s fast-growing digital ... Explore how Tufts Center for the Study of Drug Development has spearheaded the growth of digital clinical trials through an initial leap of faith
Digital JP Morgan Week 2025 – Trân Lê and Sohit Gatiganti pharmaphorum sits down for a quick chat with the Grove.AI team about their new AI agent for clinical trial recruitment.
R&D Tech & Trials: Recruiting is hard, AI can make it easier Recruiting for clinical trials is hard… and expensive.
News Tenax trounced by phase 3 heart failure readout Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.